APA (7th ed.) Citation

SW, P., C, H., M, C., M, C., G, C., JA, D., . . . AD, S. (2022). Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia, 28(4), 548. https://doi.org/10.1111/hae.14563

Chicago Style (17th ed.) Citation

SW, Pipe, et al. "Eptacog Beta Efficacy and Safety in the Treatment and Control of Bleeding in Paediatric Subjects (<12 Years) with Haemophilia A or B with Inhibitors." Haemophilia : The Official Journal of the World Federation of Hemophilia 28, no. 4 (2022): 548. https://doi.org/10.1111/hae.14563.

MLA (9th ed.) Citation

SW, Pipe, et al. "Eptacog Beta Efficacy and Safety in the Treatment and Control of Bleeding in Paediatric Subjects (<12 Years) with Haemophilia A or B with Inhibitors." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 28, no. 4, 2022, p. 548, https://doi.org/10.1111/hae.14563.